Cytokine-induced fungicidal activity of human polymorphonuclear leukocytes against Penicillium marneffei

N Kudeken1, K Kawakami, A Saito

  • 1The First Department of Internal Medicine, Faculty of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa, Japan.

Insights

Human immune cells called polymorphonuclear leukocytes (PMN) show fungicidal activity against Penicillium marneffei. Cytokines like GM-CSF enhance PMN

Area of Science:

  • Immunology
  • Mycology
  • Cell Biology

Background:

  • Penicillium marneffei is an emerging fungal pathogen causing infections in humans.
  • Human polymorphonuclear leukocytes (PMN) are key immune cells involved in combating infections.
  • The fungicidal mechanisms of PMN against P. marneffei are not fully understood.

Purpose of the Study:

  • To investigate the fungicidal activity of human PMN against Penicillium marneffei.
  • To determine the effect of PMN-activating cytokines on PMN antifungal activity.
  • To elucidate the role of PMN in host resistance to P. marneffei infection.

Main Methods:

  • In vitro co-culture of P. marneffei yeast cells with human PMN.
  • Microscopic examination of yeast germination and hyphal transformation.
  • Assessment of PMN activity with and without various cytokines (GM-CSF, G-CSF, IL-8, IFN-gamma, TNF-alpha).

Main Results:

  • Unstimulated PMN inhibited fungal growth and germination in a dose-dependent manner.
  • Granulocyte-macrophage colony stimulating factor (GM-CSF), G-CSF, and IFN-gamma enhanced PMN activity from fungistatic to fungicidal.
  • All tested cytokines enhanced PMN's inhibitory effects on P. marneffei germination and morphology, with GM-CSF showing the strongest effect.
  • Combined cytokine use did not result in synergistic enhancement of PMN antifungal activity.

Conclusions:

  • Cytokine-activated PMN exhibit significant antifungal activity against P. marneffei by suppressing growth and germination.
  • PMN, particularly when activated by cytokines like GM-CSF, play a crucial role in host defense against P. marneffei infections.
  • These findings highlight the potential of PMN-based therapies for managing P. marneffei infections.